139 related articles for article (PubMed ID: 32398249)
1. Choroidal osteoma: the varied response of subretinal fluid to anti-VEGF agents.
Narang S; Sindhu M; Sheoran K; Kaur R
BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32398249
[TBL] [Abstract][Full Text] [Related]
2. Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: An optical coherence tomography angiography study.
Furino C; Di Antonio L; Grassi MO; Rispoli M; Reibaldi M; Niro A; Alessio G
Eur J Ophthalmol; 2019 May; 29(3):323-329. PubMed ID: 30101614
[TBL] [Abstract][Full Text] [Related]
3. Choroidal Osteoma Accompanied by Proliferative Diabetic Retinopathy.
Choi HS; Kim YK; Park SP
Korean J Ophthalmol; 2018 Dec; 32(6):521-522. PubMed ID: 30549478
[No Abstract] [Full Text] [Related]
4. Spontaneous Resolution of Subretinal Detachment in Choroidal Osteoma Unresponsive to Antivascular Endothelial Growth Factor Agent and Multimodal Imaging: A Case Report.
Lee HJ; Woo SJ
Korean J Ophthalmol; 2023 Feb; 37(1):82-84. PubMed ID: 36796349
[No Abstract] [Full Text] [Related]
5. Focal choroidal excavation and pitchfork sign in choroidal neovascularisation associated with choroidal osteoma.
Rajabian F; Arrigo A; Grazioli A; Sperti A; Bandello F; Battaglia Parodi M
Eur J Ophthalmol; 2021 Mar; 31(2):NP67-NP70. PubMed ID: 31813301
[TBL] [Abstract][Full Text] [Related]
6. Sequential imaging of a case of choroidal osteoma using swept-source OCT and optical coherence tomography angiography: A 4-year follow-up study.
Basavaraj TM; Galiyugavaradhan S
Indian J Ophthalmol; 2019 Dec; 67(12):2097-2100. PubMed ID: 31755474
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma.
Morris RJ; Prabhu VV; Shah PK; Narendran V
Indian J Ophthalmol; 2011; 59(5):394-6. PubMed ID: 21836351
[TBL] [Abstract][Full Text] [Related]
8. Bilateral choroidal osteoma with choroidal neovascular membrane treated with bevacizumab in a child.
Agarwal M; Kantha M; Mayor R; Venkatesh R; Shroff CM
Middle East Afr J Ophthalmol; 2014; 21(3):265-7. PubMed ID: 25100914
[TBL] [Abstract][Full Text] [Related]
9. Choroidal Osteoma with Choroidal Neovascular Membrane treated with Anti- vascular Endothelial Growth Factor: A Rare Case with Review of Literatures.
Dorji P; Lepcha NT; Thapa R
Nepal J Ophthalmol; 2021 Jul; 13(24):196-201. PubMed ID: 35996784
[TBL] [Abstract][Full Text] [Related]
10. Successful use of anti-VEGF treatment for subretinal hemorrhage and fluid in a young patient with choroidal osteoma.
Carle MV; Chu TG; Liao D; Boyer DS
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):169-71. PubMed ID: 24635160
[TBL] [Abstract][Full Text] [Related]
11. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
Romdhane K; Zola M; Matet A; Daruich A; Elalouf M; Behar-Cohen F; Mantel I
Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of anti-vascular endothelial growth factor therapy in the management of choroidal neovascularization associated with choroidal osteoma.
Khan MA; DeCroos FC; Storey PP; Shields JA; Garg SJ; Shields CL
Retina; 2014 Sep; 34(9):1750-6. PubMed ID: 24936941
[TBL] [Abstract][Full Text] [Related]
13. [Intravitreal injection of bevacizumab for CNV secondary to choroidal osteoma and follow-up by Spectral-Domain OCT].
Mercé E; Korobelnik JF; Delyfer MN; Rougier MB
J Fr Ophtalmol; 2012 Sep; 35(7):508-13. PubMed ID: 22695057
[TBL] [Abstract][Full Text] [Related]
14. Retinal pigment epithelium tear formation following intravitreal ranibizumab injection in choroidal neovascularization secondary to choroidal osteoma.
Erol MK; Coban DT; Ceran BB; Bulut M
Cutan Ocul Toxicol; 2014 Sep; 33(3):259-63. PubMed ID: 24517498
[TBL] [Abstract][Full Text] [Related]
15. Concurrent management of myopic choroidal neovascularization and rhegmatogenous retinal detachment with intravitreal antivascular endothelial growth factor during primary retinal detachment repair.
Saurabh K; Roy R; Thomas NR; Chowdhury M
Indian J Ophthalmol; 2018 Mar; 66(3):472-474. PubMed ID: 29480274
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.
Song JH; Bae JH; Rho MI; Lee SC
Retina; 2010 Jun; 30(6):945-51. PubMed ID: 20531145
[TBL] [Abstract][Full Text] [Related]
17. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D
Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838
[TBL] [Abstract][Full Text] [Related]
18. Optical Coherence Tomography Angiography for Detecting Choroidal Neovascularization Secondary to Choroidal Osteoma.
Szelog JT; Bonini Filho MA; Lally DR; de Carlo TE; Duker JS
Ophthalmic Surg Lasers Imaging Retina; 2016 Jan; 47(1):69-72. PubMed ID: 26731212
[TBL] [Abstract][Full Text] [Related]
19. Predicting Visual Outcomes in Choroidal Osteoma Treated with Anti-vascular Endothelial Growth Factor.
Kang HG; Kim TY; Lee J; Byeon SH; Kim SS; Kim M
Am J Ophthalmol; 2022 Dec; 244():143-151. PubMed ID: 35970208
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab in the management of choroidal neovascular membrane secondary to choroidal osteoma.
Narayanan R; Shah VA
Eur J Ophthalmol; 2008; 18(3):466-8. PubMed ID: 18465736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
